Individual Investors Invested in Shenzhen Chipscreen Biosciences Co., Ltd. (SHSE:688321) Copped the Brunt of Last Week's CN¥384m Market Cap Decline
Individual Investors Invested in Shenzhen Chipscreen Biosciences Co., Ltd. (SHSE:688321) Copped the Brunt of Last Week's CN¥384m Market Cap Decline
Key Insights
主要见解
- Significant control over Shenzhen Chipscreen Biosciences by individual investors implies that the general public has more power to influence management and governance-related decisions
- The top 25 shareholders own 48% of the company
- Using data from company's past performance alongside ownership research, one can better assess the future performance of a company
- 个人投资者对微芯生物的重大控制意味着普通民众有更多的影响力,能够影响管理和治理方面的决策。
- 该公司前 25 名股东拥有该公司的 48%。
- 通过公司过去的业绩数据和股权研究,人们可以更好地评估一家公司的未来表现。
Every investor in Shenzhen Chipscreen Biosciences Co., Ltd. (SHSE:688321) should be aware of the most powerful shareholder groups. We can see that individual investors own the lion's share in the company with 52% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.
深圳市微芯生物股份有限公司(SHSE:688321)的每个投资者都应该了解最强大的股东组。我们可以看到,个人投资者拥有该公司52%的所有权。换句话说,这个群体从他们的投资中获得了最多(或者失去了最多)。
And last week, individual investors endured the biggest losses as the stock fell by 5.5%.
上周个人投资者遭受了最大的损失,因为股票下跌了5.5%。
Let's delve deeper into each type of owner of Shenzhen Chipscreen Biosciences, beginning with the chart below.
让我们深入研究每种股东类型,从下面的图表开始。
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240725/0-5fe8f340f892cd22553988b9557fb1d7-0-9c6c3b2141e41ace4d97dba882907a99.png/big)
What Does The Institutional Ownership Tell Us About Shenzhen Chipscreen Biosciences?
机构的持股情况对微芯生物有何启示?
Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.
许多机构衡量其业绩的标准是一个近似于当地市场的指数。因此,他们通常更加关注包括在主要指数中的公司。
Shenzhen Chipscreen Biosciences already has institutions on the share registry. Indeed, they own a respectable stake in the company. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Shenzhen Chipscreen Biosciences, (below). Of course, keep in mind that there are other factors to consider, too.
微芯生物已经有机构登记在股份注册簿上。实际上,它们拥有公司的相当大的股份。这意味着专业投资者中有一定的信誉度。但不能仅仅依靠这一事实,因为机构有时会做出错误的投资,就像每个人一样。如果两个大型机构投资者同时试图抛售股票,价格下跌也是很常见的。因此,值得检查微芯生物的过去收益轨迹(如下所示)。当然,也要记住考虑其他因素。
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240725/0-5fe8f340f892cd22553988b9557fb1d7-1-9329aa182ad08cc922a8a3e351681828.png/big)
We note that hedge funds don't have a meaningful investment in Shenzhen Chipscreen Biosciences. CapitalBio Corporation is currently the largest shareholder, with 8.6% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 5.7% and 5.5%, of the shares outstanding, respectively. Xian-Ping Lu, who is the third-largest shareholder, also happens to hold the title of Chairman of the Board.
我们注意到,对微芯生物没有任何有意义的对冲基金投资。现时最大的股东是CapitalBio Corporation,持有公司8.6%的股份。同时,第二和第三大股东分别持有公司5.7%和5.5%的流通股。第三大股东卢祥平先生也正好是董事会主席。
Our studies suggest that the top 25 shareholders collectively control less than half of the company's shares, meaning that the company's shares are widely disseminated and there is no dominant shareholder.
我们的研究表明,前25大股东共控制了公司股份的不到一半,这意味着公司的股份广泛分散,没有主导股东。
While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There is some analyst coverage of the stock, but it could still become more well known, with time.
虽然研究一家公司的机构所有权数据是有意义的,但研究分析师的情绪也是有意义的,以了解风向正在往哪里吹。虽然有一些分析师对该股票进行了覆盖,但随着时间的推移,它可能仍然会变得更加知名。
Insider Ownership Of Shenzhen Chipscreen Biosciences
微芯生物的内部持股情况
While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.
虽然内部人员的具体定义可能是主观的,但几乎所有人都认为董事会成员是内部人员。公司管理层应向董事会回答问题,后者应代表股东的利益。值得注意的是,有时高层管理人员也会成为董事会成员。
Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.
当内部人持股情况表明领导层思考和公司真正所有者一样时,内部所有权是积极的。然而,高达内部人士所有权也可能为公司内的小团体带来巨大的权力。在某些情况下,这可能是负面的。
We can see that insiders own shares in Shenzhen Chipscreen Biosciences Co., Ltd.. In their own names, insiders own CN¥407m worth of stock in the CN¥6.6b company. Some would say this shows alignment of interests between shareholders and the board. But it might be worth checking if those insiders have been selling.
我们可以看到,内部人士在深圳市微芯生物股份有限公司拥有股份,内部人士拥有价值40700万人民币的股票,在总共66亿的公司中拥有股份。有些人会说这证明了股东和董事会之间的利益一致。但值得检查的是这些内部人士是否一直在抛售股票。
General Public Ownership
一般大众所有权
The general public -- including retail investors -- own 52% of Shenzhen Chipscreen Biosciences. This size of ownership gives investors from the general public some collective power. They can and probably do influence decisions on executive compensation, dividend policies and proposed business acquisitions.
普通公众——包括零售投资者——拥有深圳市微芯生物 52%的股份。这种所有权规模赋予了普通公众一些集体权力。他们可以并且可能影响执行薪酬、股息政策和拟议业务收购的决策。
Private Company Ownership
私有公司的所有权
It seems that Private Companies own 33%, of the Shenzhen Chipscreen Biosciences stock. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.
似乎私人公司拥有深圳市微芯生物股票的33%。私人公司可能是相关方。有时内部人士通过私人公司的持股来表明其在公共公司中的利益,而不是以个人的身份。虽然很难得出任何广泛的结论,但值得注意为进一步研究的领域。
Next Steps:
下一步:
It's always worth thinking about the different groups who own shares in a company. But to understand Shenzhen Chipscreen Biosciences better, we need to consider many other factors. Consider for instance, the ever-present spectre of investment risk. We've identified 2 warning signs with Shenzhen Chipscreen Biosciences , and understanding them should be part of your investment process.
考虑到持有股份的不同群体是值得思考的。但要更好地了解微芯生物,我们需要考虑许多其他因素。例如,不断存在的投资风险。我们已经识别出微芯生物的2个警告信号,理解它们应该成为你的投资过程的一部分。
If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.
如果您像我一样,可能希望考虑这家公司是否会增长或缩小。幸运的是,您可以查看此免费报告,显示分析师对其未来的预测。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注:本文中的数据是使用最后一个财务报表日期结束的为期12个月的数据计算的。这可能与全年年度报告数据不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。